Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of artificial intelligence on retinal disease management: Vision Academy retinal expert consensus.
Danese C, Kale AU, Aslam T, Lanzetta P, Barratt J, Chou YB, Eldem B, Eter N, Gale R, Korobelnik JF, Kozak I, Li X, Li X, Loewenstein A, Ruamviboonsuk P, Sakamoto T, Ting DSW, van Wijngaarden P, Waldstein SM, Wong D, Wu L, Zapata MA, Zarranz-Ventura J. Danese C, et al. Among authors: eldem b. Curr Opin Ophthalmol. 2023 Sep 1;34(5):396-402. doi: 10.1097/ICU.0000000000000980. Epub 2023 Jul 13. Curr Opin Ophthalmol. 2023. PMID: 37326216 Free PMC article. Review.
Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus.
Chou YB, Kale AU, Lanzetta P, Aslam T, Barratt J, Danese C, Eldem B, Eter N, Gale R, Korobelnik JF, Kozak I, Li X, Li X, Loewenstein A, Ruamviboonsuk P, Sakamoto T, Ting DSW, van Wijngaarden P, Waldstein SM, Wong D, Wu L, Zapata MA, Zarranz-Ventura J. Chou YB, et al. Among authors: eldem b. Curr Opin Ophthalmol. 2023 Sep 1;34(5):403-413. doi: 10.1097/ICU.0000000000000979. Epub 2023 Jul 13. Curr Opin Ophthalmol. 2023. PMID: 37326222 Free PMC article. Review.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Short-term effect of macular edema on the peripapillary retinal nerve fiber layer in patients with wet age-related macular degeneration and diabetic macular edema: A comparative study.
Dikmetas O, Gungor G, Kapucu Y, Kocabeyoglu S, Kadayıfcılar S, Eldem B, Karahan S, Cankaya AB. Dikmetas O, et al. Among authors: eldem b. Photodiagnosis Photodyn Ther. 2023 Jun;42:103602. doi: 10.1016/j.pdpdt.2023.103602. Epub 2023 May 9. Photodiagnosis Photodyn Ther. 2023. PMID: 37169170
Multimodal Imaging of Severe Oxalate Retinopathy in a 20-Month-Old Boy.
Aygün FB, Kadayifcilar S, Lotfi Sadigh S, Ozaltin F, Eldem B. Aygün FB, et al. Among authors: eldem b. Ophthalmic Surg Lasers Imaging Retina. 2022 Dec;53(12):697-700. doi: 10.3928/23258160-20221114-01. Epub 2022 Dec 1. Ophthalmic Surg Lasers Imaging Retina. 2022. PMID: 36547966
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial.
Masson R, Mazurkiewicz-Bełdzińska M, Rose K, Servais L, Xiong H, Zanoteli E, Baranello G, Bruno C, Day JW, Deconinck N, Klein A, Mercuri E, Vlodavets D, Wang Y, Dodman A, El-Khairi M, Gorni K, Jaber B, Kletzl H, Gaki E, Fontoura P, Darras BT; FIREFISH Study Group. Masson R, et al. Lancet Neurol. 2022 Dec;21(12):1110-1119. doi: 10.1016/S1474-4422(22)00339-8. Epub 2022 Oct 14. Lancet Neurol. 2022. PMID: 36244364 Clinical Trial.
Expert recommendations for the management of diabetic macular edema with intravitreal dexamethasone implant: A Turkish Delphi study.
Batıoğlu F, Yanık Ö, Saatçi AO, Eldem B, Akkın C, Afrashi F, Özdemir H, Menteş J, Güngör K, Karabaş L, Karaçorlu M, Demircan N, Koçak N, Kır N, Ünlü N, Avcı R, Arvas S, Dündar SO, Kadayıfçılar S, Kaynak S, Özdek Ş, Ovalı T. Batıoğlu F, et al. Among authors: eldem b. Eur J Ophthalmol. 2023 Jan;33(1):398-407. doi: 10.1177/11206721221117695. Epub 2022 Aug 4. Eur J Ophthalmol. 2023. PMID: 35924358
The management of neovascular age-related macular degeneration: A systematic literature review of patient-reported outcomes, patient mental health and caregiver burden.
Gale RP, Finger RP, Eldem B, Aslam T, Barratt J, Daien V, Kodjikian L, Loewenstein A, Okada M, Wong TY, Sylvanowicz M, Rodríguez FJ. Gale RP, et al. Among authors: eldem b. Acta Ophthalmol. 2023 Feb;101(1):e26-e42. doi: 10.1111/aos.15201. Epub 2022 Jul 5. Acta Ophthalmol. 2023. PMID: 35790079 Free PMC article. Review.
87 results